AUPH vs. AZN
AUPH (Aurinia Pharmaceuticals Inc.) and AZN (AstraZeneca PLC) are both stocks. Both are in the Healthcare sector — AUPH in Biotechnology, AZN in Drug Manufacturers - General. Over the past 10 years, AUPH returned 17.98%/yr vs 14.81%/yr for AZN. At a 0.16 correlation, their price movements are largely independent.
Performance
AUPH vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AUPH achieves a -1.76% return, which is significantly higher than AZN's -2.12% return. Over the past 10 years, AUPH has outperformed AZN with an annualized return of 17.98%, while AZN has yielded a comparatively lower 14.81% annualized return.
AUPH
- 1D
- 1.82%
- 1M
- -0.63%
- YTD
- -1.76%
- 6M
- 5.10%
- 1Y
- 95.87%
- 3Y*
- 17.99%
- 5Y*
- 4.66%
- 10Y*
- 17.98%
AZN
- 1D
- -0.66%
- 1M
- -3.91%
- YTD
- -2.12%
- 6M
- -0.95%
- 1Y
- 26.16%
- 3Y*
- 9.19%
- 5Y*
- 11.73%
- 10Y*
- 14.81%
AUPH vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | -1.76% | 77.62% | -0.11% | 108.10% | -81.11% | 65.37% | -31.74% | 197.07% | 50.55% | 115.71% |
AZN AstraZeneca PLC | -2.12% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
Correlation
The correlation between AUPH and AZN is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Sep 4, 2014 | 0.16 |
The correlation between AUPH and AZN shifts across timeframes, from 0.14 (5 years) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
AUPH:
$2.16B
AZN:
$275.17B
AUPH:
$2.15
AZN:
$6.66
AUPH:
7.30
AZN:
26.48
AUPH:
0.00
AZN:
0.04
AUPH:
7.30
AZN:
4.55
AUPH:
3.80
AZN:
5.81
AUPH:
$298.30M
AZN:
$60.44B
AUPH:
$267.70M
AZN:
$49.37B
AUPH:
$153.45M
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUPH vs. AZN — Risk / Return Rank
AUPH
AZN
AUPH vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AUPH | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.20 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 6.06 | 1.71 | +4.35 |
| Martin ratioReturn relative to average drawdown | 13.22 | 4.70 | +8.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AUPH | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 1.05 | +1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.07 | 0.49 | -0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.60 | -0.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.49 | -0.32 |
Drawdowns
AUPH vs. AZN - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for AUPH and AZN.
Loading charts...
Drawdown Indicators
| AUPH | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.58% | -48.94% | -38.64% |
Max Drawdown (1Y)Largest decline over 1 year | -15.91% | -15.43% | -0.48% |
Max Drawdown (3Y)Largest decline over 3 years | -60.80% | -27.87% | -32.93% |
Max Drawdown (5Y)Largest decline over 5 years | -87.58% | -27.87% | -59.71% |
Max Drawdown (10Y)Largest decline over 10 years | -87.58% | -27.87% | -59.71% |
Current DrawdownCurrent decline from peak | -52.63% | -15.43% | -37.20% |
Average DrawdownAverage peak-to-trough decline | -49.22% | -11.37% | -37.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.28% | 5.60% | +1.68% |
Volatility
AUPH vs. AZN - Volatility Comparison
Aurinia Pharmaceuticals Inc. (AUPH) has a higher volatility of 10.84% compared to AstraZeneca PLC (AZN) at 6.36%. This indicates that AUPH's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AUPH | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.84% | 6.36% | +4.48% |
Volatility (6M)Calculated over the trailing 6-month period | 24.40% | 17.06% | +7.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.17% | 25.18% | +19.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.49% | 23.94% | +43.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.99% | 24.90% | +49.09% |
Dividends
AUPH vs. AZN - Dividend Comparison
AUPH has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 3.02%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 3.02% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
Financials
AUPH vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AUPH vs. AZN - Profitability Comparison
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
AUPH and AZN have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AUPH has higher volatility (10.84%) compared to AZN (6.36%). In terms of maximum drawdown, AUPH dropped -87.58% vs AZN's -48.94%.
AUPH currently has the higher Sharpe Ratio (2.13 vs 1.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AUPH and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer